SCHEMBL159128

SCHEMBL159128

Cc1nc(Nc2nc(C(F)(F)c3ccc(F)cn3)nc3ccccc23)c[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE2 O96020 10/20 0.40
CCNE1 P24864 10/20 0.40
CDK2 P24941 10/20 0.40
CDK4 P11802 5/20 0.38
CCND1 P24385 5/20 0.38
TLR7 Q9NYK1 3/20 0.37
JAK2 O60674 3/20 0.37
CYP3A4 P08684 3/20 0.37
CYP2C8 P10632 3/20 0.37
CYP2C9 P11712 3/20 0.37
JAK1 P23458 3/20 0.37
TYK2 P29597 3/20 0.37
CYP2C19 P33261 3/20 0.37
JAK3 P52333 3/20 0.37
ADORA3 P0DMS8 2/20 0.37
CYP1A2 P05177 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
NTRK1 P04629 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL165657 0.83 JAK2 (0.56) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL173974 0.81 CCNE2 (0.39) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL159127 0.80 JAK2 (0.56) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL162857 0.79 JAK2 (0.43) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL160631 0.78 GSK3A (0.56) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL174033 0.77 CCNE2 (0.39) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL163559 0.73 AURKA (0.56) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL161223 0.73 CCNE2 (0.36) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL162466 0.73 METAP1 (0.38) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL160401 0.72 NTRK1 (0.53) JAK2CYP3A4CYP2C8CYP2C9JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611789-A1 QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP disclosed
WO-2012030948-A1 QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed